MTM(SH:688029) Xin Lang Cai Jing·2025-09-04 06:33Company Overview - Nanwei Medical Technology Co., Ltd. is located in Jiangbei New District, Nanjing, Jiangsu Province, and was established on May 10, 2000. The company went public on July 22, 2019. Its main business involves the research, development, manufacturing, and sales of minimally invasive medical devices [1] - The revenue composition of the company is as follows: endoscopic consumables account for 77.80%, other categories 13.17%, tumor intervention 7.28%, visualization 1.00%, and other supplementary products 0.74% [1] Stock Performance - On September 4, Nanwei Medical's stock fell by 5.01%, trading at 87.20 CNY per share, with a transaction volume of 238 million CNY and a turnover rate of 1.41%. The total market capitalization is 16.38 billion CNY [1] Shareholder Information - Among the top ten circulating shareholders of Nanwei Medical, Huabao Fund's Huabao CSI Medical ETF (512170) increased its holdings by 127,100 shares in the second quarter, bringing its total to 3.6822 million shares, which represents 1.96% of the circulating shares. The estimated floating loss today is approximately 16.9381 million CNY [2] - The Huabao CSI Medical ETF (512170) was established on May 20, 2019, with a latest scale of 26.147 billion CNY. Year-to-date returns are 19.16%, ranking 2230 out of 4222 in its category; the one-year return is 42.08%, ranking 2091 out of 3789; and since inception, the return is 16.77% [2]